We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Inexpensive Multipurpose Point-of-Care Analyzer Unveiled at 2015 AACC Annual Meeting

By LabMedica International staff writers
Posted on 29 Jul 2015

An inexpensive point-of-care (POC) instrument capable of performing multiple clinical laboratory blood tests was unveiled at the 2015 AACC Annual Meeting & Clinical Lab Expo (Atlanta, GA, USA).

Investigators from DiaSys Diagnostics India (Mumbai, India) unveiled their new QDx InstaLab POC blood chemistry device. This instrument combines inexpensive microfluidic cartridge technology with novel nanomaterial-based plastic electrochemical biosensors.

The QDx InstaLab can perform all of the clinical tests that are routinely ordered as part of a yearly physical exam to evaluate organ function and check for conditions such as diabetes, liver disease, and kidney disease. Furthermore, the instrument can determine cholesterol levels and screen for bleeding problems.

The instrument was designed to perform these tests using samples comprising a few drops of blood from a finger prick. Results are available in three to 10 minutes or less.

“In areas where cost and efficiency are of paramount importance, labs will be able to consolidate all instrumentation into a single QDx InstaLab,” said Dr. Vijaywanth Mathur, head of research and development at DiaSys Diagnostics India. “This breakthrough technology will revolutionize and enable quality healthcare for all in low to middle income and high income countries, and particularly in rural, semirural, second tier, and third tier cities where there is no access to healthcare diagnostics or the cost per test is so high.”

Related Links:
2015 AACC Annual Meeting & Clinical Lab Expo
DiaSys Diagnostics India

Visit expo >

Gold Member

Quality Control Material

iPLEX Pro Exome QC Panel

POC Helicobacter Pylori Test Kit
Hepy Urease Test

Clinical Chemistry System

P780

Gel Cards

DG Gel Cards

Latest AACC 2015 News

Channels

Clinical Chemistry

view channel

Simple Blood Test Offers New Path to Alzheimer’s Assessment in Primary Care

Timely evaluation of cognitive symptoms in primary care is often limited by restricted access to specialized diagnostics and invasive confirmatory procedures. Clinicians need accessible tools to determine... Read more

Existing Hospital Analyzers Can Identify Fake Liquid Medical Products

Counterfeit and substandard medicines remain a serious global health threat, with World Health Organization estimates suggesting that 10.5% of medicines in low- and middle-income countries are either fake... Read more

Rapid Blood Testing Method Aids Safer Decision-Making in Drug-Related Emergencies

Acute recreational drug toxicity is a frequent reason for emergency department visits, yet clinicians rarely have access to confirmatory toxicology results in real time. Instead, treatment decisions are... Read more

New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment

Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more

Molecular Diagnostics

view channel

Image: The urine-based genetic test enables earlier detection of lynch syndrome-linked urinary tract cancers (Photo courtesy of 123RF)

Genetic Test Aids Early Detection and Improved Treatment for Cancers

Lynch syndrome is a hereditary genetic condition that significantly increases the risk of several cancers, including those of the bowel and urinary tract. Urinary tract cancers—affecting the kidney, bladder,... Read more

New Genome Sequencing Technique Measures Epstein-Barr Virus in Blood

The Epstein–Barr virus (EBV) infects up to 95% of adults worldwide and remains in the body for life. While usually kept under control, the virus is linked to cancers such as Hodgkin’s lymphoma and autoimmune... Read more

Blood Test Boosts Early Detection of Brain Cancer

Brain and central nervous system (CNS) tumors are often diagnosed at an advanced stage, when treatment options are limited, and survival rates remain low. Around 300,000 new cases are diagnosed each year... Read more

Changes In Lymphatic Vessels Can Aid Early Identification of Aggressive Oral Cancer

Oral cancers are the most common malignant tumors in the head and neck region and cause more than 188,000 deaths worldwide each year. Unlike many other cancers, even small, early-stage oral tumors can... Read more

Hematology

view channel

$Image: Hemex Health’s Gazelle platform is designed to rapidly separate and detect hemoglobin fractions and variants using miniaturized electrophoresis technology (photo courtesy of Hemex Health)$

Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis

Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more

New Guidelines Aim to Improve AL Amyloidosis Diagnosis

Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more

Image: The new device can fit in the palm and is capable of measuring the quality of red blood cells (Photo courtesy of Xiaoyun Ding)

Fast and Easy Test Could Revolutionize Blood Transfusions

Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more

Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow

High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more

Immunology

view channel

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response

Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more

Microbiology

view channel

Three-Test Panel Launched for Detection of Liver Fluke Infections

Parasitic liver fluke infections remain endemic in parts of Asia, where transmission commonly occurs through consumption of raw freshwater fish or aquatic plants. Chronic infection is a well-established... Read more

Image: NG-TEST Candida auris is the first lateral-flow immunoassay specifically designed to identify C. auris from cultured specimens within 15 minutes (Photo courtesy of NG Biotech)

Rapid Test Promises Faster Answers for Drug-Resistant Infections

Drug-resistant pathogens continue to pose a growing threat in healthcare facilities, where delayed detection can impede outbreak control and increase mortality. Candida auris is notoriously difficult to... Read more

CRISPR-Based Technology Neutralizes Antibiotic-Resistant Bacteria

Antibiotic resistance has accelerated into a global health crisis, with projections estimating more than 10 million deaths per year by 2050 as drug-resistant “superbugs” continue to spread.... Read more

Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Pathology

view channel

Image: The AI-powered 3D cytology platform detects abnormal cells with near-expert accuracy (Photo courtesy of CYBO)

AI-Powered 3D Scanning System Speeds Cancer Screening

Cytology remains a cornerstone of cancer detection, requiring specialists to examine bodily fluids and cells under a microscope. This labor-intensive process involves inspecting up to one million cells... Read more

Image: The innovative classifier can guide treatment for PDAC and other immunotherapy-resistant cancers (Photo courtesy of Adobe Stock))

Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, in part because of its dense tumor microenvironment that influences how tumors grow and respond to treatment.... Read more

New AI-Driven Platform Standardizes Tuberculosis Smear Microscopy Workflow

Sputum smear microscopy remains central to tuberculosis treatment monitoring and follow-up, particularly in high‑burden settings where serial testing is routine. Yet consistent, repeatable bacillary assessment... Read more

AI Tool Uses Blood Biomarkers to Predict Transplant Complications Before Symptoms Appear

Stem cell and bone marrow transplants can be lifesaving, but serious complications may arise months after patients leave the hospital. One of the most dangerous is chronic graft-versus-host disease, in... Read more

Technology

view channel

Image: The model estimates when Alzheimer’s symptoms will begin based on the accumulation of amyloid and tau proteins in the brain (Photo courtesy of Sara Moser/WashU Medicine)

Blood Test “Clocks” Predict Start of Alzheimer’s Symptoms

More than 7 million Americans live with Alzheimer’s disease, and related health and long-term care costs are projected to reach nearly USD 400 billion in 2025. The disease has no cure, and symptoms often... Read more

mage: The AI-derived MYCN niche score predicts liver cancer risk before tumors form (Photo courtesy of Adobe Stock)

AI-Powered Biomarker Predicts Liver Cancer Risk

Liver cancer, or hepatocellular carcinoma, causes more than 800,000 deaths worldwide each year and often goes undetected until late stages. Even after treatment, recurrence rates reach 70% to 80%, contributing... Read more

Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals

Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read more

Industry

view channel

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more

AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America

Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its AI-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year agreement.... Read more